Article

Oral agent shows durable improvement in SUI patients

San Diego-Treatment with the dual neurotransmitter reuptake inhibitor duloxetine (Yentreve) results in durable improvement in symptoms of stress urinary incontinence, according to a study of open-label transition from placebo to active therapy.

Related Videos
Woman talking with doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
Karyn S. Eilber, MD, answers a question during a Zoom video interview
Anna Myers, CNP, answers a question during a Zoom video interview
Drug costs | Image Credit: © pixelrobot - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.